NO992872D0 - Spiro(piperidin-4,1'-pyrrole(3,4-c)pyrrol - Google Patents

Spiro(piperidin-4,1'-pyrrole(3,4-c)pyrrol

Info

Publication number
NO992872D0
NO992872D0 NO992872A NO992872A NO992872D0 NO 992872 D0 NO992872 D0 NO 992872D0 NO 992872 A NO992872 A NO 992872A NO 992872 A NO992872 A NO 992872A NO 992872 D0 NO992872 D0 NO 992872D0
Authority
NO
Norway
Prior art keywords
pyrrole
spiro
piperidine
Prior art date
Application number
NO992872A
Other languages
English (en)
Other versions
NO992872L (no
NO312069B1 (no
Inventor
Geo Adam
Frank Dautzenberg
Sabine Kolczewski
Stephan Roever
Juergen Wichmann
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO992872D0 publication Critical patent/NO992872D0/no
Publication of NO992872L publication Critical patent/NO992872L/no
Publication of NO312069B1 publication Critical patent/NO312069B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Addiction (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO19992872A 1998-06-12 1999-06-11 Spiro(piperidin-4,1'-pyrrolo(3,4-c)pyrroler, fremgangsmåte for fremstilling og anvendelse derav, og medikament inneholdendedisse NO312069B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98110803 1998-06-12
EP98124119 1998-12-18

Publications (3)

Publication Number Publication Date
NO992872D0 true NO992872D0 (no) 1999-06-11
NO992872L NO992872L (no) 1999-12-13
NO312069B1 NO312069B1 (no) 2002-03-11

Family

ID=26149342

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19992872A NO312069B1 (no) 1998-06-12 1999-06-11 Spiro(piperidin-4,1'-pyrrolo(3,4-c)pyrroler, fremgangsmåte for fremstilling og anvendelse derav, og medikament inneholdendedisse

Country Status (27)

Country Link
US (1) US6075034A (no)
EP (1) EP0963987B1 (no)
JP (1) JP3308507B2 (no)
KR (1) KR100346607B1 (no)
AR (1) AR018650A1 (no)
AT (1) ATE222908T1 (no)
AU (1) AU749995B2 (no)
BR (1) BR9902245A (no)
CA (1) CA2274204C (no)
CO (1) CO5060459A1 (no)
DE (1) DE69902606T2 (no)
DK (1) DK0963987T3 (no)
ES (1) ES2181336T3 (no)
HR (1) HRP990189A2 (no)
HU (1) HUP9901909A3 (no)
ID (1) ID23283A (no)
IL (1) IL130376A0 (no)
MA (1) MA26643A1 (no)
NO (1) NO312069B1 (no)
NZ (1) NZ336186A (no)
PE (1) PE20000549A1 (no)
PL (1) PL333694A1 (no)
PT (1) PT963987E (no)
SG (1) SG76623A1 (no)
TR (1) TR199901304A2 (no)
TW (1) TW523516B (no)
YU (1) YU26599A (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002224038B2 (en) 2000-11-15 2006-03-09 Banyu Pharmaceutical Co., Ltd. Benzimidazole derivatives
JP2005502619A (ja) * 2001-07-02 2005-01-27 オメロス コーポレイション オピオイドレセプター様レセプター１アゴニストと交替でオピオイドレセプターアゴニストを投与することを含む、痛覚脱失を生成するための方法
US20030040479A1 (en) * 2001-07-02 2003-02-27 Omeros Corporation Rotational intrathecal analgesia method and device
JP2005289816A (ja) 2002-05-14 2005-10-20 Banyu Pharmaceut Co Ltd ベンズイミダゾール誘導体
US20080287478A1 (en) * 2003-05-23 2008-11-20 Lars Bo Laurenborg Hansen Nociceptin Analogues and Uses Thereof
US20050228023A1 (en) * 2003-12-19 2005-10-13 Sri International Agonist and antagonist ligands of the nociceptin receptor
JP4446978B2 (ja) * 2006-04-28 2010-04-07 トヨタ自動車株式会社 車両用駆動力制御装置
AU2008219980B2 (en) * 2007-03-01 2012-01-12 Mitsubishi Tanabe Pharma Corporation Benzimidazole compound and pharmaceutical use thereof
KR101561666B1 (ko) 2014-08-12 2015-10-20 최인석 골프 퍼팅 교정장치

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534520A (en) * 1990-04-10 1996-07-09 Fisher; Abraham Spiro compounds containing five-membered rings
CA2226058C (en) * 1997-01-30 2008-01-29 F. Hoffmann-La Roche Ag 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives

Also Published As

Publication number Publication date
US6075034A (en) 2000-06-13
ID23283A (id) 2000-04-05
DE69902606T2 (de) 2003-04-24
KR20000006079A (ko) 2000-01-25
EP0963987A2 (en) 1999-12-15
AU749995B2 (en) 2002-07-04
NZ336186A (en) 2000-10-27
EP0963987A3 (en) 2001-01-17
PL333694A1 (en) 1999-12-20
CA2274204C (en) 2009-09-15
DE69902606D1 (de) 2002-10-02
HUP9901909A2 (hu) 2000-04-28
TR199901304A3 (tr) 2000-01-21
MA26643A1 (fr) 2004-12-20
NO992872L (no) 1999-12-13
YU26599A (sh) 2002-09-19
SG76623A1 (en) 2000-11-21
TR199901304A2 (xx) 2000-01-21
AR018650A1 (es) 2001-11-28
HUP9901909A3 (en) 2001-11-28
KR100346607B1 (ko) 2002-08-07
EP0963987B1 (en) 2002-08-28
AU3500399A (en) 1999-12-23
PE20000549A1 (es) 2000-07-24
CO5060459A1 (es) 2001-07-30
BR9902245A (pt) 2000-03-21
NO312069B1 (no) 2002-03-11
TW523516B (en) 2003-03-11
ATE222908T1 (de) 2002-09-15
CA2274204A1 (en) 1999-12-12
HRP990189A2 (en) 2000-02-29
ES2181336T3 (es) 2003-02-16
HU9901909D0 (en) 1999-08-30
DK0963987T3 (da) 2002-12-30
JP3308507B2 (ja) 2002-07-29
PT963987E (pt) 2003-01-31
JP2000053680A (ja) 2000-02-22
IL130376A0 (en) 2000-06-01

Similar Documents

Publication Publication Date Title
DE59409351D1 (de) Pyrrolo[3,4-c]pyrrole
PT1087971E (pt) Compostos de pirrolo[2,3-d]piridina
DK1087970T3 (da) Pyrrol[2,3-d]pyrimidin forbindelser
DE69905652T2 (de) Direkte Herstellung von Pyrrolo-(3,4-c)pyrrolpigmenten
EG24605A (en) Antihistaminic spiro compounds
ZA992072B (en) Substituted pyrroles.
NO962320D0 (no) Tricykliske 5,6-dihydro-9H-pyrazolo [3,4cÅ-1,2,4-triazolo [4,3-aÅ pyridiner
TR199901381A3 (tr) Diaza-spiro[3,5]nonan türevleri.
NO992872L (no) Spiro(piperidin-4,1'-pyrrole(3,4-c)pyrrol
HK1040991A1 (zh) 2-雜芳基-3，4-二氫-2h-吡咯衍生物
ZA993853B (en) Spiro[piperidine-4,1'-pyrolo(3,4-C)pyrrole].
DE59606457D1 (de) Monophasige feste Lösungen mit asymmetrischen Pyrrolo-[4,3-c]-pyrrolen als Wirten
IL137351A0 (en) Heterocyclic topoisomerase poisons
ZA974538B (en) Novel pyrrole derivatives.
DE59510186D1 (de) Cyaniminogruppen enthaltende Pyrrolo(3,4-c)pyrrole
DE59500031D1 (de) Aminoxidgruppen enthaltende Pyrrolo[3,4-c]pyrrole als Photorezeptoren
GB9827314D0 (en) Novel heterocyclic colouring matters
PL325562A1 (en) Novel derivative of pyrrole[3,4-c]pyridine or 3,4-pyridinodicarboxyimide